Chronic Myelogenous Leukemia, BCR-ABL1 Positive in Remission

2 clinical trials · Condition

Record	Firm	Date
Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant (NCT03192397)	Roswell Park Cancer Institute	2017-08-09
Ruxolitinib in Treating Participants With Chronic Myeloid Leukemia With Minimal Residual Disease While on Therapy With Tyrosine Kinase Inhibitors (NCT01751425)	M.D. Anderson Cancer Center	2013-07-24

Every clearance here is in the API, with alerts when new ones post.